Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin

Photochemistry and Photobiology

Volumn 69, Issue 1, 1999, Pages 61-70

  Robinson, Dominic J ^a   De Bruijn, Henriëtte S ^a   Van Der Veen, Nynke ^a   Stringer, Mark R ^b   Brown, Stanley B ^b   Star, Willem M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANIMAL; ARTICLE; BIOLOGY; FEMALE; FLUORESCENCE; HAIRLESS MOUSE; MALE; MOUSE; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; RADIATION INJURY; SKIN TUMOR; ULTRAVIOLET RADIATION;

AMINOLEVULINIC ACID; ANIMALS; FEMALE; FLUORESCENCE; MALE; MICE; MICE, INBRED HRS; NEOPLASMS, RADIATION-INDUCED; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0032616985     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1999.tb05307.x     Document Type: Article

References (20)

1. Robinson, D. J., H. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown and W. M. Star (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem. Photobiol. 67, 140-149.
2. Van der Veen, N., H. L. L. M, van Leengoed and W. M. Star (1994). In-vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br. J. Cancer 70, 867-872.
3. Foster, T. H., R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson and R. Hilf (1991) Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126, 296-303.
4. Messmann, H., P. Mlkvy, G. Buonaccorsi, C. L. Davies, A. J. MacRobert and S. G. Bown (1995) Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced photosensitisation on normal rat colon by threshold and light fractionation studies. Br. J. Cancer 72, 589-594.
5. Hua Z. X., S. L. Gibson, T. H. Foster and R. Hilf (1995) Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in-vivo. Cancer Res. 55, 1723-1731.
6. Van der Veen, N., H. S. de Bruijn, R. J. W. Berg and W. M. Star (1996) Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumors of UVB-treated mice. Br. J. Cancer 73, 925-930.
7. Van der Veen, N., H. S. de Bruijn and W. M. Star (1997) Photobleaching during and re-appearance after photodynamic therapy of topical ALA induced fluorescence in UVB-treated mouse skin. Int. J. Cancer 72, 110-118.
8. Georgakoudi, I., M. G. Nichols and T. H. Foster (1997) The mechanism of Photofrin® photobleaching and its consequences for photodynamic therapy. Photochem. Photobiol. 65, 135-144.
9. Georgakoudi, I. and T. H. Foster (1998) Photobleaching of PpIX, NBSe and NBS during photodynamic therapy of multicellular tumor spheroids. Photochem. Photobiol. 67, 612-625.
10. Forrer, T. M., T. Glanzmann, D. Braichotte, G. Wagnières, H. van den Bergh, J. F. Savary and P. Monnier (1995) In-vivo measurement of fluorescence bleaching of meso-tetra hydroxyphenylchlorin (mTHPC) in the oesophagus and the oral cavity. Proc. Soc. Photo-Opt. Inst. Eng. 2627, 33-39.
11. Gruijl, F. R., J. B. van der Meer and J. C. Van derLeun (1983) Dose-time dependency of tumor formation by chronic UV exposure. Photochem. Photobiol. 37, 53-62.
12. Weagle, W., P. E. Paterson, J. C. Kennedy and R. Pottier (1988) The nature of the chromophore responsible for the naturally occurring fluorescence in mouse skin. J. Photochem. Photobiol. B Biol. 2, 313-320.
13. Gijsbers, G. H. M., D. Breederveld, M. J. C. van Gemert, T. A. Boon, J. Langelaar and R. P. H. Rettschnick (1986) In-vivo fluorescence excitation and emission spectra of hematoporphyrin-derivative. Lasers Life Sci. 1, 29-48.
14. Wilson, B. C., M. S. Patterson and L. Lilge (1997) Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med. Sci. 12, 182-199.
15. Dietel, W., C Fritsch, R. H. Pottier and R. Wendenburg (1997) 5-Aminolaevulinic-acid-induced formation of different porphyrins and their photomodifications. Lasers Med. Sci. 12, 226-236.
16. Foster, T. H. and L. Gao (1992) Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density. Radiat. Res. 130, 379-383.
17. Gudgin Dickson, E. F. and R. H. Pottier (1995) On the role of protoporphyrin IX photoproducts in photodynamic therapy. J. Photochem. Photobiol. B Biol. 29, 91-93.
18. Rhodes, L. E., M Tsoukas, R. Anderson and N. Kollias (1997) Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J. Invest. Dermatol. 108, 87-91.
19. Potter, W. R., D. A. Bellnier, R. Pandy, J. C. Parsons and T. J. Dougherty (1997) Sensitizer pharmacokinetics by in vivo reflectance spectroscopy. Photochem. Photobiol. 67, 000-000.
20. Star, W. M., J. P.A Marijissen, A. E. van den Berg-Blok, A. A. C. Versteeg, N. A. P Franken and H. S. Reinhold (1986) Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in a sandwich observation chamber. Cancer Res. 46, 2532-2540.